|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.73 USD | -1.47% |
|
+14.59% | -21.27% |
| 07/04 | UBS Adjusts Price Target on Helen of Troy to $16 From $22, Maintains Neutral Rating | MT |
| 17/03 | Revlon Hair Tools Announces Launch of Versastyler Three-In-One Hair Tool | CI |
| Fiscal Period: February | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 8.73 | 6.76 | 5.31 | 5.43 | 4.47 | |||||
Return on Total Capital | 11.39 | 8.98 | 6.53 | 6.48 | 5.34 | |||||
Return On Equity % | 21.15 | 17.44 | 10.18 | 10.79 | 7.45 | |||||
Return on Common Equity | 21.15 | 17.44 | 10.18 | 10.79 | 7.45 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 44.18 | 42.87 | 43.39 | 47.31 | 47.93 | |||||
SG&A Margin | 28.23 | 28.24 | 28.68 | 31.01 | 32.64 | |||||
EBITDA Margin % | 15.66 | 13.98 | 13.91 | 15.03 | 14.08 | |||||
EBITA Margin % | 14.7 | 12.95 | 12.64 | 13.37 | 12.18 | |||||
EBIT Margin % | 13.86 | 12.37 | 11.75 | 12.46 | 11.19 | |||||
Income From Continuing Operations Margin % | 12.1 | 10.06 | 6.91 | 8.41 | 6.49 | |||||
Net Income Margin % | 12.1 | 10.06 | 6.91 | 8.41 | 6.49 | |||||
Net Avail. For Common Margin % | 12.1 | 10.06 | 6.91 | 8.41 | 6.49 | |||||
Normalized Net Income Margin | 8.29 | 7.37 | 6.07 | 6.18 | 5.27 | |||||
Levered Free Cash Flow Margin | 6.89 | 1.19 | 0.94 | 12.37 | 3.94 | |||||
Unlevered Free Cash Flow Margin | 7.22 | 1.5 | 2.12 | 13.95 | 5.57 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.01 | 0.87 | 0.72 | 0.7 | 0.64 | |||||
Fixed Assets Turnover | 12.57 | 10.79 | 6.54 | 5.25 | 5.17 | |||||
Receivables Turnover (Average Receivables) | 5.75 | 5.29 | 4.96 | 5.19 | 4.64 | |||||
Inventory Turnover (Average Inventory) | 3.18 | 2.44 | 2.32 | 2.48 | 2.34 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.58 | 1.8 | 2.16 | 1.87 | 2 | |||||
Quick Ratio | 0.71 | 0.82 | 1.01 | 0.94 | 0.98 | |||||
Operating Cash Flow to Current Liabilities | 0.51 | 0.23 | 0.51 | 0.68 | 0.24 | |||||
Days Sales Outstanding (Average Receivables) | 63.52 | 68.96 | 73.54 | 70.47 | 78.72 | |||||
Days Outstanding Inventory (Average Inventory) | 114.96 | 149.37 | 157.64 | 147.5 | 155.92 | |||||
Average Days Payable Outstanding | 63.69 | 87.14 | 85.01 | 80.03 | 89.48 | |||||
Cash Conversion Cycle (Average Days) | 114.78 | 131.18 | 146.17 | 137.95 | 145.16 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 32.11 | 65.21 | 66.11 | 43.43 | 57.2 | |||||
Total Debt / Total Capital | 24.3 | 39.47 | 39.8 | 30.28 | 36.39 | |||||
LT Debt/Equity | 31.12 | 64.52 | 65.22 | 42.55 | 56.28 | |||||
Long-Term Debt / Total Capital | 23.55 | 39.05 | 39.26 | 29.66 | 35.8 | |||||
Total Liabilities / Total Assets | 45.25 | 52.99 | 48.9 | 42.32 | 46.25 | |||||
EBIT / Interest Expense | 23.06 | 21.41 | 5.98 | 4.75 | 4.11 | |||||
EBITDA / Interest Expense | 26.8 | 25.24 | 7.48 | 6.01 | 5.48 | |||||
(EBITDA - Capex) / Interest Expense | 18.98 | 19.16 | 3.18 | 5.32 | 4.9 | |||||
Total Debt / EBITDA | 1.18 | 2.67 | 3.23 | 2.25 | 3.39 | |||||
Net Debt / EBITDA | 1.04 | 2.57 | 3.12 | 2.18 | 3.31 | |||||
Total Debt / (EBITDA - Capex) | 1.66 | 3.52 | 7.59 | 2.54 | 3.79 | |||||
Net Debt / (EBITDA - Capex) | 1.47 | 3.38 | 7.33 | 2.46 | 3.7 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 22.92 | 5.93 | -6.78 | -3.26 | -4.86 | |||||
Gross Profit, 1 Yr. Growth % | 26.26 | 2.79 | -5.65 | 5.48 | -3.61 | |||||
EBITDA, 1 Yr. Growth % | 27.48 | -5.39 | -7.26 | 8.65 | -10.86 | |||||
EBITA, 1 Yr. Growth % | 27.69 | -6.71 | -8.98 | 6.84 | -13.32 | |||||
EBIT, 1 Yr. Growth % | 32 | -5.44 | -11.42 | 7.38 | -14.52 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 66.7 | -11.89 | -35.97 | 17.67 | -26.6 | |||||
Net Income, 1 Yr. Growth % | 66.7 | -11.89 | -35.97 | 17.67 | -26.6 | |||||
Normalized Net Income, 1 Yr. Growth % | 32.33 | -5.74 | -23.2 | 4.1 | -18.81 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 67.44 | -9.03 | -35.11 | 18.15 | -23.61 | |||||
Accounts Receivable, 1 Yr. Growth % | 9.89 | 19.66 | -17.49 | 4.48 | 8.57 | |||||
Inventory, 1 Yr. Growth % | 87.9 | 15.86 | -18.37 | -13.06 | 14.3 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 2.62 | 43.81 | 60.63 | -4.59 | -2.02 | |||||
Total Assets, 1 Yr. Growth % | 18.89 | 24.74 | 3.2 | -2.58 | 10.34 | |||||
Tangible Book Value, 1 Yr. Growth % | 17.63 | -212.1 | -17.46 | -125.86 | -294.66 | |||||
Common Equity, 1 Yr. Growth % | 6.68 | 7.1 | 12.16 | 9.98 | 2.81 | |||||
Cash From Operations, 1 Yr. Growth % | 15.78 | -55.17 | 47.87 | 46.98 | -63.01 | |||||
Capital Expenditures, 1 Yr. Growth % | 455.59 | -20.91 | 124.07 | -79.04 | -17.93 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 13.21 | -81.78 | -25.93 | 1.86T | -69.71 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 12.99 | -77.96 | 31.35 | 655.81 | -61.98 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 15.84 | 14.11 | -0.62 | -5.04 | -4.06 | |||||
Gross Profit, 2 Yr. CAGR % | 20.27 | 13.92 | -1.52 | -0.24 | 0.83 | |||||
EBITDA, 2 Yr. CAGR % | 19.12 | 9.82 | -6.33 | -1.55 | -3.25 | |||||
EBITA, 2 Yr. CAGR % | 19.55 | 9.14 | -7.86 | -3.48 | -5.55 | |||||
EBIT, 2 Yr. CAGR % | 20.1 | 11.72 | -8.48 | -4.7 | -6.11 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 20.73 | 21.2 | -24.89 | -13.2 | -7.06 | |||||
Net Income, 2 Yr. CAGR % | 22.75 | 21.2 | -24.89 | -13.2 | -7.06 | |||||
Normalized Net Income, 2 Yr. CAGR % | 20.51 | 11.69 | -14.91 | -13.05 | -10.3 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 23.4 | 23.46 | -23.17 | -12.44 | -5 | |||||
Accounts Receivable, 2 Yr. CAGR % | 16.81 | 14.67 | -0.64 | -7.15 | 6.51 | |||||
Inventory, 2 Yr. CAGR % | 26.21 | 47.55 | -2.75 | -15.76 | -0.32 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 13.89 | 21.48 | 51.99 | 23.79 | -3.31 | |||||
Total Assets, 2 Yr. CAGR % | 17.14 | 21.78 | 13.46 | 0.27 | 3.68 | |||||
Tangible Book Value, 2 Yr. CAGR % | 17.61 | 14.83 | -3.81 | -53.8 | -29.05 | |||||
Common Equity, 2 Yr. CAGR % | 11.51 | 6.89 | 9.6 | 11.07 | 6.34 | |||||
Cash From Operations, 2 Yr. CAGR % | 26.82 | -27.95 | -18.58 | 47.43 | -26.27 | |||||
Capital Expenditures, 2 Yr. CAGR % | 93.38 | 109.63 | 33.13 | -31.48 | -58.53 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 19.21 | -54.58 | -63.26 | 206.69 | 100.78 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 18.39 | -50.09 | -46.19 | 189.31 | 57.26 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 12.38 | 12.44 | 6.67 | -1.51 | -4.98 | |||||
Gross Profit, 3 Yr. CAGR % | 14.91 | 14.13 | 6.98 | 0.76 | -1.38 | |||||
EBITDA, 3 Yr. CAGR % | 13.16 | 10.31 | 3.8 | -2.85 | -4.76 | |||||
EBITA, 3 Yr. CAGR % | 13.34 | 10.06 | 2.73 | -4.57 | -6.88 | |||||
EBIT, 3 Yr. CAGR % | 14.64 | 10.9 | 3.4 | -4.95 | -8.09 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 25.37 | 8.7 | -2.02 | -12.76 | -17.92 | |||||
Net Income, 3 Yr. CAGR % | 78.77 | 9.91 | -2.02 | -12.76 | -17.92 | |||||
Normalized Net Income, 3 Yr. CAGR % | 16.42 | 11.04 | -1.42 | -10.68 | -15.02 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 28.69 | 11.47 | -0.37 | -11.32 | -16.34 | |||||
Accounts Receivable, 3 Yr. CAGR % | 11.54 | 17.75 | 2.76 | 1.04 | -2.18 | |||||
Inventory, 3 Yr. CAGR % | 24.18 | 22.66 | 21.13 | -6.32 | -6.74 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 11.04 | 23.1 | 33.34 | 30.14 | 14.51 | |||||
Total Assets, 3 Yr. CAGR % | 11.71 | 19.62 | 15.24 | 7.84 | 3.52 | |||||
Tangible Book Value, 3 Yr. CAGR % | 9.19 | 15.74 | 2.86 | -37.92 | -25.38 | |||||
Common Equity, 3 Yr. CAGR % | 6.9 | 10.02 | 8.62 | 9.73 | 8.24 | |||||
Cash From Operations, 3 Yr. CAGR % | 11.89 | -10.33 | -8.44 | -0.86 | -7.02 | |||||
Capital Expenditures, 3 Yr. CAGR % | 93.56 | 43.54 | 114.34 | -28.12 | -27.23 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -6.4 | -36.26 | -46.54 | 19.67 | 41.77 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -6.31 | -32.4 | -31.1 | 22.65 | 47.09 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 8.55 | 9.73 | 6.98 | 5.09 | 2.24 | |||||
Gross Profit, 5 Yr. CAGR % | 12.02 | 10.7 | 8.03 | 8.15 | 4.48 | |||||
EBITDA, 5 Yr. CAGR % | 12.67 | 8.19 | 4.92 | 5.41 | 0.83 | |||||
EBITA, 5 Yr. CAGR % | 12.98 | 8.04 | 4.33 | 4.43 | -0.77 | |||||
EBIT, 5 Yr. CAGR % | 14.76 | 9.65 | 4.76 | 4.38 | -0.63 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 22.25 | 9.17 | 2.14 | -0.65 | -4.07 | |||||
Net Income, 5 Yr. CAGR % | 20.2 | 9.73 | 26.38 | 0.01 | -4.07 | |||||
Normalized Net Income, 5 Yr. CAGR % | 15.42 | 10.38 | 2.7 | 0.69 | -5.2 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 25.56 | 12.14 | 4.7 | 1.21 | -2.25 | |||||
Accounts Receivable, 5 Yr. CAGR % | 11.95 | 14.81 | 6.5 | 7.08 | 4.24 | |||||
Inventory, 5 Yr. CAGR % | 9.81 | 14.72 | 12.61 | 5.55 | 12.04 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 5.32 | 13.96 | 25.89 | 23.38 | 17.25 | |||||
Total Assets, 5 Yr. CAGR % | 4.13 | 9.26 | 12.41 | 11.47 | 10.47 | |||||
Tangible Book Value, 5 Yr. CAGR % | 37.71 | 14.09 | 3.79 | -19.84 | -11.34 | |||||
Common Equity, 5 Yr. CAGR % | 5.91 | 5.39 | 7.97 | 10.44 | 7.7 | |||||
Cash From Operations, 5 Yr. CAGR % | 10.98 | -9.23 | -1.47 | 9.4 | -16.04 | |||||
Capital Expenditures, 5 Yr. CAGR % | 42.7 | 38.15 | 66.65 | 6.79 | 11.11 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 0.82 | -29.53 | -35.61 | 19.49 | -10.08 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 0.91 | -26.9 | -24.95 | 20.93 | -4.54 |
- Stock Market
- Equities
- HELE Stock
- Financials Helen of Troy Limited
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















